• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Gains 100 Points Following PCE Data

    2/29/24 10:40:00 AM ET
    $CC
    $ENVB
    $IRWD
    $LPSN
    Major Chemicals
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CC alert in real time by email

    U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday.

    Following the market opening Thursday, the Dow traded down 0.07% to 38,923.11 while the NASDAQ rose 0.65% to 16,051.57. The S&P 500 also rose, gaining, 0.30% to 5,084.74.

    Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Communication services shares rose by 0.9% on Thursday.

    In trading on Thursday, health care shares fell by 0.6%.

     

    Top Headline

     

    The annual PCE inflation rate eased slightly from 2.6% in December 2023 to 2.4% in January 2024. Excluding energy and food, the core PCE index saw a year-on-year surge of 2.8%, down from the 2.9% rate seen December and in line with the expected decrease to 2.8%.

     

    Equities Trading UP

     

    Societal CDMO, Inc. (NASDAQ:SCTL) shares shot up 132% to $1.0686. Privately held CoreRx Inc. will acquire Societal CDMO, a contract development and manufacturing organization.

    Shares of Enveric Biosciences, Inc. (NASDAQ:ENVB) got a boost, surging 130% to $1.91. Enveric Biosciences signed a non-binding term sheets to pursue the exclusive out-licensing of three classes of compounds.

    Volcon, Inc. (NASDAQ:VLCN) shares were also up, gaining 58% to $1.9101 after surging around 39% on Wednesday.

     

    Equities Trading DOWN

     

    LivePerson, Inc. (NASDAQ:LPSN) shares dropped 40% to $1.4395 following fourth-quarter financial results.

    Shares of The Chemours Company (NYSE:CC) were down 40% to $17.20 after the company announced executive changes and said it is delaying its fourth quarter results and 10-K.

    Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) was down, falling 39% to $9.19 after the company announced topline results from global Phase III trial of once-weekly apraglutide in adults with short bowel syndrome with intestinal failure (SBS-IF).

    Also Check This Out: Top 3 Energy Stocks That Could Sink Your Portfolio In Q1

     

    Commodities

     

    In commodity news, oil traded down 0.4% to $78.23 while gold traded up 0.6% at $2,055.70.

    Silver traded rose 0.9% to $22.84 on Thursday while copper rose 0.4% to $3.8540.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 rose 0.2%, London’s FTSE 100 rose 0.3% while Spain’s IBEX 35 Index fell 0.4% The German DAX gained 0.6% French CAC 40 fell 0.1% while Italy’s FTSE MIB Index declined 0.1%.

    German jobless rate held came in unchanged at 5.9% in February, while German retail sales fell by 0.4% month-over-month in January. Spanish annual consumer price inflation rate declined to a six-month low level of 2.8% in February.

    French economy expanded 0.1% on quarter in the fourth quarter. The annual inflation rate in France eased to 2.9% in February, while producer prices declined 1.3% month-over-month in January.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Thursday, with Japan’s Nikkei 225 falling 0.11%, Hong Kong’s Hang Seng Index falling 0.15%, China’s Shanghai Composite Index gaining 1.94% and India’s S&P BSE Sensex gaining 0.27%.

    Indian fiscal deficit shrank to INR 11.03 trillion in April-January compared to INR 11.91 trillion in the year-ago period. Japanese housing starts fell by 7.5% year-over-year in January following a 4.0% decline in the previous month. Retail sales in Japan gained 2.3% year-over-year in January.

     

    Economics

     

    The annual PCE inflation rate eased slightly from 2.6% in December 2023 to 2.4% in January 2024. Excluding energy and food, the core PCE index saw a year-on-year surge of 2.8%, down from the 2.9% rate seen December and in line with the expected decrease to 2.8%.

    Personal spending rose by 0.2% from the previous month, while personal income rose by 1%.

    U.S. initial jobless claims rose by 13,000 to 215,000 in the week ending Feb. 24.

    Now Read This: Cramer Says This AI Stock Is Just An Nvidia Play, Prefers This Stock Over Anheuser-Busch

     

    Get the next $CC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CC
    $ENVB
    $IRWD
    $LPSN

    CompanyDatePrice TargetRatingAnalyst
    Ironwood Pharmaceuticals Inc.
    $IRWD
    1/5/2026$8.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Ironwood Pharmaceuticals Inc.
    $IRWD
    4/15/2025Overweight → Equal Weight
    Wells Fargo
    Ironwood Pharmaceuticals Inc.
    $IRWD
    4/15/2025Buy → Hold
    Jefferies
    Ironwood Pharmaceuticals Inc.
    $IRWD
    4/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    Chemours Company
    $CC
    3/27/2025$19.00Neutral → Outperform
    Mizuho
    Chemours Company
    $CC
    1/28/2025$27.00Buy
    Truist
    LivePerson Inc.
    $LPSN
    11/8/2024$1.00Buy → Hold
    Craig Hallum
    Ironwood Pharmaceuticals Inc.
    $IRWD
    9/9/2024$5.00Market Perform
    Leerink Partners
    More analyst ratings

    $CC
    $ENVB
    $IRWD
    $LPSN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ironwood Pharma upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Ironwood Pharma from Mkt Perform to Mkt Outperform and set a new price target of $8.00

    1/5/26 8:35:09 AM ET
    $IRWD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ironwood Pharma downgraded by Wells Fargo

    Wells Fargo downgraded Ironwood Pharma from Overweight to Equal Weight

    4/15/25 9:27:22 AM ET
    $IRWD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ironwood Pharma downgraded by Jefferies

    Jefferies downgraded Ironwood Pharma from Buy to Hold

    4/15/25 9:27:01 AM ET
    $IRWD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CC
    $ENVB
    $IRWD
    $LPSN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call

    WILMINGTON, Del., Feb. 4, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its fourth quarter 2025 financial results after market on Thursday, February 19, 2026. The Company expects to hold its conference call to discuss its fourth quarter 2025 financial results at 8:00 a.m. Eastern Time on Friday, February 20, 2026. The call is open to the public and can be accessed via the webcast information below. The webcast and materials can be accessed by visiting the "Events and Presentations" section of

    2/4/26 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option

    RCANN™ Trademark Portfolio Out-Licensed Enveric Biosciences, Inc. (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that its subsidiary, Akos Biosciences, has licensed to TOTEC Pharma, Inc. ("TOTEC") its US Trademark portfolio for RCANN™ and an RCANN™ design. TOTEC, an affiliate of Aries Science & Technology ("Aries"), is advancing the commercialization of patented cannabinoid crème technology created by Enveric and intended for use in treatment of radiation dermatitis. The trademark license to TOTEC includes an option to purchase the RCANN trad

    1/29/26 8:00:00 AM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

    Enveric Biosciences, Inc. (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 328,802 shares of common stock at a purchase price of $4.41 per share. In a concurrent private placement, the Company issued unregistered series G warrants to purchase up to 328,802 shares of common stock and unregistered series H warrants to purchase up to 328,802 shares of common stock. The series G warrants have an exercise price of $4.16

    1/28/26 5:00:00 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CC
    $ENVB
    $IRWD
    $LPSN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Dignam Denise bought $49,060 worth of shares (4,068 units at $12.06) (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    8/12/25 5:12:16 PM ET
    $CC
    Major Chemicals
    Industrials

    Officer Gumpel Damian bought $201,376 worth of shares (21,222 units at $9.49), increasing direct ownership by 19% to 131,701 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    6/4/25 8:32:18 PM ET
    $CC
    Major Chemicals
    Industrials

    Chief Financial Officer Hostetter Shane bought $50,196 worth of shares (4,450 units at $11.28), increasing direct ownership by 8% to 59,694 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    5/21/25 5:13:57 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    $ENVB
    $IRWD
    $LPSN
    SEC Filings

    View All

    Enveric Biosciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Enveric Biosciences, Inc. (0000890821) (Filer)

    2/6/26 4:45:30 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by Enveric Biosciences Inc.

    424B5 - Enveric Biosciences, Inc. (0000890821) (Filer)

    2/6/26 4:30:15 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Enveric Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - Enveric Biosciences, Inc. (0000890821) (Filer)

    1/28/26 5:00:49 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CC
    $ENVB
    $IRWD
    $LPSN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Tech Product Officer Mina Christopher Allen sold $22,543 worth of shares (7,152 units at $3.15), decreasing direct ownership by 12% to 52,636 units (SEC Form 4)

    4 - LIVEPERSON INC (0001102993) (Issuer)

    1/20/26 5:55:42 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    CFO and COO Collins John Deneen was granted 34,193 shares, increasing direct ownership by 42% to 116,007 units (SEC Form 4)

    4 - LIVEPERSON INC (0001102993) (Issuer)

    1/7/26 9:18:53 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    Principal Accounting Officer Silver Ronald sold $162,914 worth of shares (35,416 units at $4.60), decreasing direct ownership by 11% to 276,809 units (SEC Form 4)

    4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)

    1/7/26 4:05:09 PM ET
    $IRWD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CC
    $ENVB
    $IRWD
    $LPSN
    Leadership Updates

    Live Leadership Updates

    View All

    ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

    ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today announced the appointment of David Johnson as Chairman of the Board. Mr. Johnson will work alongside CEO, Doron Besser, and the existing leadership team. David Johnson, newly appointed Chairman of ENvue, stated, "We believe ENvue is at the forefront of advanced feeding-tube placement technology, which has been validated in the market and extensively used in the clinic across 38 hospitals in the US. In my opinion, the Company's unique feeding tube placement system that utilizes advanced methods of navigation, integrated sensors and body mapping h

    12/15/25 9:00:00 AM ET
    $ENVB
    $FEED
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties

    Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel

    The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, today announced the appointment of Michael Foley as President of Chemours Titanium Technologies (TT), effective February 2026. Foley succeeds Damián Gumpel, who is departing the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204540269/en/Chemours appoints Michael Foley as President of Titanium Technologies Chemours thanks Mr. Gumpel for his contributions and wishes him well in his future endeavors. This transition reflects C

    12/4/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Tripp Lane Joins LivePerson Board of Directors

    NEW YORK, Nov. 17, 2025 /PRNewswire/ -- LivePerson (NASDAQ:LPSN), a leading provider of predictable conversational AI and digital transformation, today announced that Nathan "Tripp" Lane has been appointed to its Board of Directors. "We are excited to welcome Tripp to the LivePerson Board," said Jim Miller, Board Chair. "Tripp's extensive experience guiding technology companies on strategy, operational effectiveness, and business transformation as a board director, operator, and investment advisor provides a unique perspective that will be an asset as we focus on execution and

    11/17/25 8:30:00 AM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    $CC
    $ENVB
    $IRWD
    $LPSN
    Financials

    Live finance-specific insights

    View All

    Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call

    WILMINGTON, Del., Feb. 4, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its fourth quarter 2025 financial results after market on Thursday, February 19, 2026. The Company expects to hold its conference call to discuss its fourth quarter 2025 financial results at 8:00 a.m. Eastern Time on Friday, February 20, 2026. The call is open to the public and can be accessed via the webcast information below. The webcast and materials can be accessed by visiting the "Events and Presentations" section of

    2/4/26 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan

    WILMINGTON, Del., Jan. 15, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today signed a set of definitive agreements to sell the remaining land1 at its former titanium dioxide manufacturing location in Kuan Yin, Taiwan to an ownership group including Century Wind Power Co., Ltd., Century Iron & Steel Industrial Co., Ltd., and Century Huaxin Wind Energy, Co., Ltd. The land sale will generate approximately $360 million2 in gross cash proceeds, prior to customary taxes and fees. The tra

    1/15/26 5:01:00 PM ET
    $CC
    Major Chemicals
    Industrials

    LivePerson Announces Third Quarter 2025 Financial Results

    -- Total Revenue of $60.2 million, above the high end of our guidance range -- -- Adjusted EBITDA above the high end of our guidance range  -- NEW YORK, Nov. 10, 2025 /PRNewswire/ -- LivePerson, Inc. (NASDAQ:LPSN) ("LivePerson" the "Company", "we" or "us"), a leading provider of predictable conversational AI and digital transformation, today announced financial results for the third quarter ended September 30, 2025. Third Quarter Highlights Total revenue was $60.2 million for the third quarter of 2025, a decrease of 19.0% as compared to the same period last year, driven primar

    11/10/25 4:30:00 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    $CC
    $ENVB
    $IRWD
    $LPSN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LivePerson Inc.

    SC 13G/A - LIVEPERSON INC (0001102993) (Subject)

    11/14/24 5:21:06 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Enveric Biosciences Inc.

    SC 13G/A - Enveric Biosciences, Inc. (0000890821) (Subject)

    11/14/24 4:03:47 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Volcon Inc.

    SC 13G/A - Volcon, Inc. (0001829794) (Subject)

    11/14/24 3:49:56 PM ET
    $VLCN
    Auto Manufacturing
    Consumer Discretionary